Table 2 Patient characteristics
Overall n = 252 | ERAS Compliant (ERAS Pathways > = 10) n = 129 | ERAS Non-compliant (ERAS Pathways < 10) n = 123 | P Value | ||
|---|---|---|---|---|---|
Age | Mean ± SD | 60.07 ± 9.75 | 60.64 ± 9.14(n = 129) | 59.46 ± 10.36(n = 123) | 0.2345 |
Male | N(%) | 209(82.94%) | 106(82.17%)(n = 129) | 103(83.74%)(n = 123) | 0.7406 |
BMI | Mean ± SD | 23.38 ± 3.34 | 23.39 ± 3.32(n = 123) | 23.37 ± 3.39(n = 120) | 0.9576 |
Anemia | N(%) | 88(35.06%) | 45(35.16%)(n = 128) | 43(34.96%)(n = 123) | 0.9739 |
Abnormal Creatinine | N(%) | 22(8.80%) | 11(8.59%)(n = 128) | 11(9.02%)(n = 122) | 0.9061 |
Comorbidity | N(%) | 45(17.86%) | 27(20.93%)(n = 129) | 18(14.63%)(n = 123) | 0.1921 |
ASA ≥ 3 | N(%) | 28(12.17%) | 12(10.26%)(n = 117) | 16(14.16%)(n = 112) | 0.3655 |
Duration of surgery, min | Mean ± SD | 272.70 ± 61.12 | 274.92 ± 59.51(n = 129) | 270.37 ± 62.93(n = 123) | 0.5559 |
Blood loss, mL | median (IQR) | 100(50) | 100(50)(n = 129) | 100(100)(n = 123) | 0.5135 |
Intraoperative transfusion (Yes) | N(%) | 19(7.54%) | 8(6.20%)(n = 129) | 11(8.94%)(n = 123) | 0.4100 |
Pathologic TNM stage | 0.8760 | ||||
I A | N(%) | 31(12.30%) | 18(13.95%) | 13(10.57%) | |
I B | N(%) | 24(9.52%) | 12(9.30%) | 12(9.76%) | |
II A | N(%) | 41(16.27%) | 23(17.83%) | 18(14.63%) | |
II B | N(%) | 36(14.29%) | 15(11.63%) | 21(17.07%) | |
III A | N(%) | 53(21.03%) | 27(20.93%) | 26(21.14%) | |
III B | N(%) | 50(19.84%) | 26(20.16%) | 24(19.51%) | |
III C | N(%) | 17(6.75%) | 8(6.20%) | 9(7.32%) |